Section 1: Recipient Identification
Age (year and month of birth)
Sex (male and female)
Case number (linked to provincial number for follow-up)
Section 3: Time and Place of Incident/Adverse Reaction
Date and time of reaction
Use of equipment (pumps, blood warmer, etc)
Section 4: Clinical Signs and Laboratory Results
Fever (temperature before and after), Hypotension/Hypertension (BP before and after), Oliguria, Diffuse Hemorrhage, Urticaria, Nausea/Vomiting, Jaundice, Tachycardia, Chills/Rigors, Shortness of Breath, Shock, Death, Other skin rash, Pain, Hemoglobinuria, Other
Bacterial Infection:
Blood Culture Recipient: Negative/Positive, Organism
Identified
Blood Culture of Product: Negative/Positive, If positive, Lot #,
Organism Identified
Section 5: Suspect Products
Transfused product code or name
Hospital modification code
Autologous unit
Expiry date of product
Date and time of transfusion
Section 7: Results of Investigation & Conclusion3
Severe Allergic Reactions, e.g., Anaphylactic/Anaphylactoid -
Signs
and Symptoms
ABO Incompatibility
Acute Haemolytic Reactions
Viral Infections (type)
Bacterial Infections
Other Infections
Transfusion Related Graft-Versus-Host Disease (TR-GVHD)
TRALI
Post Transfusion Purpura
Unknown4
Others (specify)3
Severity : (Death/Life-threatening/Long-term sequelae/Minor or no
sequelae/
Not determined)
Relationship to Transfusion: (definite, probable, possible and not
determined)
[Previous] [Table of Content] [Next]